| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |